Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1960 1
1962 5
1964 2
1965 4
1966 3
1967 1
1968 2
1969 2
1970 3
1971 1
1972 1
1973 3
1974 4
1975 4
1976 5
1977 7
1978 11
1979 19
1980 6
1981 11
1982 17
1983 15
1984 13
1985 15
1986 20
1987 21
1988 20
1989 24
1990 25
1991 28
1992 26
1993 41
1994 30
1995 45
1996 42
1997 33
1998 40
1999 59
2000 49
2001 51
2002 50
2003 59
2004 62
2005 79
2006 99
2007 121
2008 143
2009 155
2010 158
2011 183
2012 204
2013 226
2014 228
2015 226
2016 208
2017 203
2018 195
2019 212
2020 247
2021 291
2022 253
2023 275
2024 147

Text availability

Article attribute

Article type

Publication date

Search Results

4,250 results

Results by year

Filters applied: . Clear all
Page 1
Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications.
Malinovska L, Cappelletti V, Kohler D, Piazza I, Tsai TH, Pepelnjak M, Stalder P, Dörig C, Sesterhenn F, Elsässer F, Kralickova L, Beaton N, Reiter L, de Souza N, Vitek O, Picotti P. Malinovska L, et al. Among authors: tsai th. Nat Protoc. 2023 Mar;18(3):659-682. doi: 10.1038/s41596-022-00771-x. Epub 2022 Dec 16. Nat Protoc. 2023. PMID: 36526727 Review.
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
Pinter A, Puig L, Schäkel K, Reich A, Zaheri S, Costanzo A, Tsai TF, Smith SD, Lynde C, Brnabic A, Reed C, Hill J, Schuster C, Riedl E, Paul C. Pinter A, et al. Among authors: tsai tf. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2087-2100. doi: 10.1111/jdv.18376. Epub 2022 Jul 29. J Eur Acad Dermatol Venereol. 2022. PMID: 35766124
Response letter.
Tsai TC. Tsai TC. Int Urol Nephrol. 2024 May;56(5):1773. doi: 10.1007/s11255-023-03830-8. Epub 2023 Oct 20. Int Urol Nephrol. 2024. PMID: 37861892 No abstract available.
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Thaçi D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG. Morita A, et al. Among authors: tsai tf. Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738999 Clinical Trial.
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
Lin WC, Tai WC, Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, Feng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wang HS, Wu IC, Kuo HY, Wu JF, Yao Shih H, Ni YH, Tang SL, Chen PH, Wei SC. Lin WC, et al. Among authors: tsai tj. Inflamm Bowel Dis. 2023 Nov 2;29(11):1730-1740. doi: 10.1093/ibd/izac269. Inflamm Bowel Dis. 2023. PMID: 36626567 Free PMC article.
Adhesion-Based Self-Organization in Tissue Patterning.
Tsai TY, Garner RM, Megason SG. Tsai TY, et al. Annu Rev Cell Dev Biol. 2022 Oct 6;38:349-374. doi: 10.1146/annurev-cellbio-120420-100215. Epub 2022 May 13. Annu Rev Cell Dev Biol. 2022. PMID: 35562853 Free PMC article. Review.
Man With Dyspnea.
Lee JY, Lin JW, Tsai TY. Lee JY, et al. Among authors: tsai ty. Ann Emerg Med. 2023 Oct;82(4):e157-e158. doi: 10.1016/j.annemergmed.2023.04.007. Ann Emerg Med. 2023. PMID: 37739757 No abstract available.
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
Langley RG, Sofen H, Dei-Cas I, Reich K, Sigurgeirsson B, Warren RB, Paul C, Szepietowski JC, Tsai TF, Hampele I, You R, Charef P, Papavassilis C. Langley RG, et al. Among authors: tsai tf. Br J Dermatol. 2023 Feb 10;188(2):198-207. doi: 10.1093/bjd/ljac040. Br J Dermatol. 2023. PMID: 36763857 Clinical Trial.
4,250 results